Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Opinion in Pharmacology|May 20, 2008
siRNA and the lung: research tool or therapeutic drug?Antonin de Fougerolles, Tatiana NovobrantsevaMethods in Enzymology|November 5, 2013
Measuring RNAi knockdown using qPCRStuart Milstein, Michael Nguyen, Rachel Meyers, et al.Current Opinion in Drug Discovery & Development|February 20, 2008
Delivering silence: advancements in developing siRNA therapeuticsTatiana I Novobrantseva, Akin Akinc, Anna Borodovsky, et al.Methods in Enzymology|January 13, 2005
RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeuticsAntonin de Fougerolles, Muthiah Manoharan, Rachel Meyers, et al.Nature Reviews. Drug Discovery|June 2, 2007
Interfering with disease: a progress report on siRNA-based therapeuticsAntonin de Fougerolles, Hans-Peter Vornlocher, John Maraganore, et al.Pharmacology & Therapeutics|July 5, 2016
Nanobodies® as inhaled biotherapeutics for lung diseasesGino Van Heeke, Koen Allosery, Veronique De Brabandere, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 25, 2005
Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- miceKitty Schapira, Esther Lutgens, Antonin de Fougerolles, et al.Nature Medicine|July 3, 2007
Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasisCurdin Conrad, Onur Boyman, Giulia Tonel, et al.Nature Medicine|February 22, 2005
Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7Veit Hornung, Margit Guenthner-Biller, Carole Bourquin, et al.Molecular Genetics and Metabolism Reports|November 30, 2016
Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe diseaseBaodong Sun, Suhrad G Banugaria, Sean N Prater, et al.Pageof 3